Literature DB >> 1350813

Cumulative conception and livebirth rates after in-vitro fertilisation.

S L Tan1, P Royston, S Campbell, H S Jacobs, J Betts, B Mason, R G Edwards.   

Abstract

Cumulative conception and livebirth rates related to age and cause of infertility provide the most useful estimate of success after in-vitro fertilisation (IVF), but limited data are available. It is also uncertain whether the probability of pregnancy, livebirth, and pregnancy failure changes with repeated treatment cycles. To assess the effects of patients' age and cause of infertility on these outcomes, we studied the results of 5055 consecutive IVF cycles (773 clinical pregnancies, 518 livebirths) undertaken on 2735 patients in a single IVF unit. Cumulative conception and livebirth rates were analysed by the life-table approach and differences in rates between age-groups and between causes of infertility were measured by the log-rank test and logistic regression modelling. Both conception and livebirth rates per cycle declined with age (p less than 0.001), and cumulative conception and livebirth rates after five treatment cycles were about 54% and 45%, respectively, at 20-34 years, compared with 38.7% and 28.9% at 35-39 years and 20.2% and 14.4% at greater than or equal to 40 years. The two rates were significantly different between causal groups (p less than 0.001 and p = 0.02, respectively) and were lowest in patients with male infertility or multiple infertility factors. The pregnancy failure rate was higher (p = 0.006) in women over the age of 34 years and there was a significant decline in the chances of pregnancy and livebirth per cycle with successive treatment cycles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1350813     DOI: 10.1016/0140-6736(92)91205-m

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Endometriosis: aetiology, pathogenesis and treatment.

Authors:  T J Child; S L Tan
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Assisted conception on the NHS?

Authors:  D T Baird
Journal:  BMJ       Date:  1992-07-25

Review 3.  Issues of quality in providing services for subfertile couples.

Authors:  F Song; J M Mason; S Ibbotson; N Freemantle; A F Long; T A Sheldon
Journal:  Qual Health Care       Date:  1992-09

Review 4.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

5.  Accelerated decline in pregnancy rate after in vitro fertilization and embryo transfer in 35-41-year-old women: 15 years' experience in the Okinawa Islands, Japan.

Authors:  Yoko Teruya; Shigeru Kamiyama; Makoto Hirakawa; Kie Yamashiro; Koji Kanazawa
Journal:  Reprod Med Biol       Date:  2006-03-01

6.  Confounding variables affecting in vitro fertilization success: a decade of experience.

Authors:  M Alsalili; A A Yuzpe; I S Tummon; J Parker; J S Martin; J A Nisker; S A Daniel
Journal:  J Assist Reprod Genet       Date:  1995-02       Impact factor: 3.412

7.  Impact of fertilization history and semen parameters on ICSI outcome.

Authors:  R Mercan; S Oehninger; S J Muasher; J P Toner; J Mayer; S E Lanzendorf
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

Review 8.  Investigating and managing infertility in general practice.

Authors:  T B Hargreave; J A Mills
Journal:  BMJ       Date:  1998-05-09

9.  Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.

Authors:  S R Lindheim; D H Barad; B Witt; E Ditkoff; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1996-10       Impact factor: 3.412

10.  The influence of advanced age on the outcome of assisted reproduction.

Authors:  J E Dew; R A Don; G J Hughes; T C Johnson; S J Steigrad
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.